Most pharmacokinetic studies assessing the brain uptake of incretin mimetics have been conducted in animals, and translating these findings to human subjects and clinical outcomes remains uncertain
Qin Y, Liu M, Guo F, Chen D, Yang P, Chen X, et al
Three things drive the gap: Not sure which GLP-1 is right for you
Some medications such as tirzepatide are referred to as a 'dual-agonist', containing an additional hormone known as gastric inhibitory polypeptide (GIP)
Gallbladder motility in obesity, diabetes mellitus and coeliac disease
Both medications: belong to the GLP-1 agonist drug class are available in an injectable and pill form have been shown to aid in weight loss Ozempic is FDA approved to manage blood sugar in adults with type 2 diabetes and help protect the kidneys in these patients